Answers are grounded in this paper and cite their sources.
Observational analysis identified key characteristics in lymphatic endothelial cells expressing NRAS Q61R, suggesting implications for lymphangiogenesis and KLA pathogenesis.
Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly characterized by lymphatic overgrowth and dysfunction. The goal of this study was to determine how the NRAS Q61R variant found in the tissue of KLA patients impacts key characteristics of lymphatic endothelial cells (LEC). LEC expressing NRAS Q61R had a spindled morphology, increased migration, increased proliferation, increased MAPK signaling, and elevated angiopoietin‐2 production. In an in vitro lymphangiogenesis model, LEC expressing NRAS Q61R showed increased sprouting and formed enlarged and disorganized vascular structures. This model of LEC expressing NRAS Q61R can be used to give insights into KLA pathogenesis and test new treatments.
No takes yet. Share an insight, caveat, or question.
Fox et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: